The ESG in Life Sciences Summit West - Mastering ESG Compliance & Strategic Sustainability in Life Sciences in 2025. As ESG becomes a key differentiator for securing business and investment, […]

“Toxicity is the killer of ADCs” and remains the primary challenge limiting ADC success in the clinic. From unpredictable off-target effects to non-translating toxicity profiles and dose limiting toxicities, the industry […]